Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets

twitter: 3 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 20 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East

Genomeweb, 26 Oct 2021

NEW YORK ─ Blueprint Genetics said Tuesday it is collaborating with BioMarin to launch a free genetic testing program for…

Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East

360Dx, 26 Oct 2021

NEW YORK ─ Blueprint Genetics said Tuesday it is collaborating with BioMarin to launch a free genetic testing program for…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.